News

HUTCHMED Hosts Expert Call on Immune Thrombocytopenia Insights

HUTCHMED Hosts Expert Call on Immune Thrombocytopenia Insights

HUTCHMED to Host Expert Call on Immune Thrombocytopenia

HUTCHMED (China) Limited (Nasdaq/AIM:HCM; HKEX:13) has announced that it will hold a physician expert call featuring a professor and key opinion leader in the field of immune thrombocytopenia (ITP). This discussion will focus on the current treatment landscape for ITP and will be available via webcast on an upcoming date at 7:00 p.m. HKT.

Event Details

The event will be conducted in Chinese (Putonghua) and can be accessed at www.hutch-med.com/event. Investors who wish to participate in the webcast should log on before the start time to ensure they have any necessary software downloaded. A transcript of the event, including an English translation, will be made available shortly after, for approximately 90 days. Please note that this event is designed exclusively for investor audiences.

About ESLIM-01 Trial

ESLIM-01 is a Phase III trial investigating HUTCHMED’s innovative investigational drug candidate, sovleplenib, in patients diagnosed with primary ITP. The trial successfully met all its endpoints, and the results were published in a well-regarded medical journal as well as presented at the European Hematology Association Hybrid Congress. Recently, HUTCHMED submitted a New Drug Application for sovleplenib.

Understanding Immune Thrombocytopenia (ITP)

Immune thrombocytopenia (ITP) is an autoimmune disorder that leads to the destruction of platelets and a reduction in their production. Patients suffering from ITP face an increased risk of excessive bleeding and bruising, along with symptoms such as fatigue and a diminished quality of life. The incidence of primary ITP in adults is approximately 3.3 cases per 100,000 adults each year, with an estimated prevalence of 9.5 per 100,000 adults. Based on this data, it is estimated that around 110,000 individuals are living with primary ITP in major markets.

Sovleplenib’s Role in Treatment

Sovleplenib is a novel, selective Syk inhibitor designed for once-daily oral administration. Syk plays a crucial role in B-cell receptor and FcR signaling, making it a promising target for various B-cell lymphomas and autoimmune disorders. HUTCHMED is currently conducting clinical investigations into sovleplenib, retaining all global rights to the drug.

Other Indications for Sovleplenib

Beyond its use in ITP, sovleplenib is also being explored for its potential in treating warm antibody autoimmune hemolytic anemia and indolent non-Hodgkin’s lymphoma.

About HUTCHMED

HUTCHMED is a forward-thinking, commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for cancer and immunological diseases. The company boasts a workforce of approximately 5,000 employees, with a significant number dedicated to oncology and immunology. HUTCHMED is committed to delivering its cancer drug candidates to patients globally, having made notable progress with its first three medicines now available in select regions.

Frequently Asked Questions

What is the purpose of the HUTCHMED expert call?

The expert call is designed to discuss the treatment landscape of immune thrombocytopenia and to provide insights regarding the company’s drug candidates.

What is sovleplenib?

Sovleplenib is a novel drug candidate currently under investigation for the treatment of ITP and other autoimmune disorders, specifically targeting Syk.

Who can attend the webcast?

The webcast is intended for investor audiences, and interested individuals should log in before the scheduled start time.

What is the incidence of ITP?

The incidence of primary ITP is approximately 3.3 cases per 100,000 adults each year.

How can I learn more about HUTCHMED?

To find out more about HUTCHMED, you can visit their official website or explore their communication channels for additional information.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 37

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 64

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 106

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 63

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Sulzer Rebuilds Petrocedeño Tower: A Milestone in Oil Revival

Updated Category News Views 85

Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...

Continue Reading
Fortvita's Zybrivo Gains CHMP Nod: A European Leap

Updated Category News Views 23

It's not every day you're reading about a biotech making a ground-breaking shift off Chinese shores, but Fortvita's latest breakthrough is worth noting. Their fancy immunotherapy, Zybrivo® (sintilimab), just snagged a nod from the CHMP, Europe's committee that guides many on the medicinal merry-go-round. This isn't just your run-of-the-mill nod either. We're talking...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 160

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 49

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 348

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading

Top 5 Most Recently Viewed Articles

Flow Beverage Welcomes José Bautista as Advisor and Announces Fundraising Progress

Updated Category News Views 336

Flow Beverage Corp. Welcomes José Bautista as Strategic Advisor Flow Beverage Corp. (TSX:FLOW; OTCQX:FLWBF) has recently made a significant move by bringing on board José Bautista as a Strategic Advisor. This addition is seen as a promising enhancement to the company's team, aligning with its dedication to excellence and innovation in the beverage sector. Background of...

Continue Reading
Milan Laser Hair Removal Marks a Significant 400 Clinic Milestone

Updated Category News Views 207

Milan Laser Hair Removal Reaches 400 Clinics Nationwide The leading provider in laser hair removal achieves a remarkable milestone with nationwide expansion efforts. Milan Laser Hair Removal, the hallmark of laser hair removal in the nation, proudly celebrates the grand opening of its 400th clinic, symbolizing a major advancement in its rapid expansion across the country....

Continue Reading
Global Vertical Roller Mill Market Expands to USD 1.04 Billion

Updated Category News Views 215

Understanding the Global Vertical Roller Mill Market The Vertical Roller Mill (VRM) market is anticipated to experience significant growth in the coming years. Currently valued at approximately USD 608.5 million in 2024, projections indicate that it will reach USD 1,041.2 million by 2033, achieving a compound annual growth rate (CAGR) of 6.1%. This increase is largely due...

Continue Reading
Pulsar Helium Provides Insights on Progress at Topaz Project

Updated Category News Views 313

Pulsar Helium Develops Well-Testing Strategy at Topaz Project Pulsar Helium Inc. (AIM: PLSR, TSXV: PLSR, OTCQB: PSRHF), a leading helium development company, has recently provided valuable updates regarding its well-testing activities at the Topaz project, located in Minnesota. This momentous phase in the project holistically aims to assess helium extraction capabilities...

Continue Reading
Trade Disclosures: Treatt plc's Key Operations Analyzed

Updated Category News Views 178

Understanding Recent Trade Disclosures by Treatt plc Treatt plc, a company known for its expertise in manufacturing and distributing essential oils and flavouring agents, operates in a competitive sector where trade disclosures play a crucial role in maintaining transparency and building investor trust. As we delve into the recent disclosures made by Treatt plc, we'll...

Continue Reading